United States Influenza Vaccine Market Report & Forecast 2021-2027

Publisher Name :
Date: 17-Sep-2021
No. of pages: 92
Inquire Before Buying

United States Influenza Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Influenza Vaccine Market Segment Percentages, By Type, 2020 (%)

- Trivalent Influenza Vaccine

- Quadrivalent Influenza Vaccine

United States Influenza Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)

United States Influenza Vaccine Market Segment Percentages, By Application, 2020 (%)

- For Children (6 months to 3 years)

- For Adults and Children over 3 years

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Influenza Vaccine revenues in United States market, 2016-2021 (Estimated), ($ millions)

Key companies Influenza Vaccine revenues share in United States market, 2020 (%)

Key companies Influenza Vaccine sales in United States market, 2016-2021 (Estimated), (M Doses)

Key companies Influenza Vaccine sales share in United States market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- CSL

- GSK

- Sanofi Pasteur

- Mylan

- Hulan Bio

- AstraZeneca

- CCBIO

United States Influenza Vaccine Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Influenza Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Influenza Vaccine Overall Market Size
2.1 United States Influenza Vaccine Market Size: 2021 VS 2027
2.2 United States Influenza Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Influenza Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Influenza Vaccine Players in United States Market
3.2 Top United States Influenza Vaccine Companies Ranked by Revenue
3.3 United States Influenza Vaccine Revenue by Companies
3.4 United States Influenza Vaccine Sales by Companies
3.5 United States Influenza Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Influenza Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Vaccine Players in United States Market
3.8.1 List of Tier 1 Influenza Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Influenza Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Influenza Vaccine Market Size Markets, 2021 & 2027
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - United States Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - United States Influenza Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Influenza Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Influenza Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Influenza Vaccine Sales & Forecasts
4.3.1 By Type - United States Influenza Vaccine Sales, 2016-2021
4.3.2 By Type - United States Influenza Vaccine Sales, 2022-2027
4.3.3 By Type - United States Influenza Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Influenza Vaccine Market Size, 2021 & 2027
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - United States Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - United States Influenza Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Influenza Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Influenza Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Influenza Vaccine Sales & Forecasts
5.3.1 By Application - United States Influenza Vaccine Sales, 2016-2021
5.3.2 By Application - United States Influenza Vaccine Sales, 2022-2027
5.3.3 By Application - United States Influenza Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Overview
6.1.3 CSL Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 CSL Influenza Vaccine Product Description
6.1.5 CSL Recent Developments
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Overview
6.2.3 GSK Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 GSK Influenza Vaccine Product Description
6.2.5 GSK Recent Developments
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Overview
6.3.3 Sanofi Pasteur Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Sanofi Pasteur Influenza Vaccine Product Description
6.3.5 Sanofi Pasteur Recent Developments
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Overview
6.4.3 Mylan Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Mylan Influenza Vaccine Product Description
6.4.5 Mylan Recent Developments
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Overview
6.5.3 Hulan Bio Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Hulan Bio Influenza Vaccine Product Description
6.5.5 Hulan Bio Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Overview
6.6.3 AstraZeneca Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 AstraZeneca Influenza Vaccine Product Description
6.6.5 AstraZeneca Recent Developments
6.7 CCBIO
6.7.1 CCBIO Corporation Information
6.7.2 CCBIO Overview
6.7.3 CCBIO Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 CCBIO Influenza Vaccine Product Description
6.7.5 CCBIO Recent Developments
7 United States Influenza Vaccine Production Capacity, Analysis
7.1 United States Influenza Vaccine Production Capacity, 2016-2027
7.2 Influenza Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Influenza Vaccine Supply Chain Analysis
9.1 Influenza Vaccine Industry Value Chain
9.2 Influenza Vaccine Upstream Market
9.3 Influenza Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Influenza Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Influenza Vaccine in United States Market
Table 2. Top Influenza Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Influenza Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Influenza Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Influenza Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. United States Influenza Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Influenza Vaccine Price (2016-2021) & (USD/Doses)
Table 8. Manufacturers Influenza Vaccine Product Type
Table 9. List of Tier 1 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Trivalent Influenza Vaccine
Table 12. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 13. By Type - United States Influenza Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Influenza Vaccine Sales (M Doses), 2016-2021
Table 17. By Type - United States Influenza Vaccine Sales (M Doses), 2022-2027
Table 18. By Application - United States Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Influenza Vaccine Sales (M Doses), 2016-2021
Table 22. By Application - United States Influenza Vaccine Sales (M Doses), 2022-2027
Table 23. CSL Corporation Information
Table 24. CSL Description and Major Businesses
Table 25. CSL Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 26. CSL Influenza Vaccine Product
Table 27. CSL Recent Developments
Table 28. GSK Corporation Information
Table 29. GSK Description and Major Businesses
Table 30. GSK Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 31. GSK Influenza Vaccine Product
Table 32. GSK Recent Developments
Table 33. Sanofi Pasteur Corporation Information
Table 34. Sanofi Pasteur Description and Major Businesses
Table 35. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 36. Sanofi Pasteur Influenza Vaccine Product
Table 37. Sanofi Pasteur Recent Developments
Table 38. Mylan Corporation Information
Table 39. Mylan Description and Major Businesses
Table 40. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 41. Mylan Influenza Vaccine Product
Table 42. Mylan Recent Developments
Table 43. Hulan Bio Corporation Information
Table 44. Hulan Bio Description and Major Businesses
Table 45. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 46. Hulan Bio Influenza Vaccine Product
Table 47. Hulan Bio Recent Developments
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Major Businesses
Table 50. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 51. AstraZeneca Influenza Vaccine Product
Table 52. AstraZeneca Recent Developments
Table 53. CCBIO Corporation Information
Table 54. CCBIO Description and Major Businesses
Table 55. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 56. CCBIO Influenza Vaccine Product
Table 57. CCBIO Recent Developments
Table 58. Influenza Vaccine Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 59. United States Influenza Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Influenza Vaccine Market Opportunities & Trends in United States Market
Table 61. Influenza Vaccine Market Drivers in United States Market
Table 62. Influenza Vaccine Market Restraints in United States Market
Table 63. Influenza Vaccine Raw Materials
Table 64. Influenza Vaccine Raw Materials Suppliers in United States Market
Table 65. Typical Influenza Vaccine Downstream
Table 66. Influenza Vaccine Downstream Clients in United States Market
Table 67. Influenza Vaccine Distributors and Sales Agents in United States Market
List of Figures
Figure 1. Influenza Vaccine Product Picture
Figure 2. Influenza Vaccine Segment by Type
Figure 3. Influenza Vaccine Segment by Application
Figure 4. United States Influenza Vaccine Market Overview: 2020
Figure 5. United States Influenza Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Influenza Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Influenza Vaccine Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Vaccine Revenue in 2020
Figure 9. Trivalent Influenza Vaccine Product Picture
Figure 10. Quadrivalent Influenza Vaccine Product Picture
Figure 11. By Type - United States Influenza Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States Influenza Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 14. For Children (6 months to 3 years)
Figure 15. For Adults and Children over 3 years
Figure 16. By Application - United States Influenza Vaccine Sales Market Share, 2016-2027
Figure 17. By Application - United States Influenza Vaccine Revenue Market Share, 2016-2027
Figure 18. By Application - United States Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 19. CSL Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. GSK Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofi Pasteur Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Mylan Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Hulan Bio Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. AstraZeneca Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. CCBIO Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Influenza Vaccine Production Capacity (M Doses), 2016-2027
Figure 27. Influenza Vaccine Industry Value Chain
Figure 28. Marketing Channels
  • Global Encephalitis Vaccination Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 102
    According to our LPI (LP Information) latest study, the global Encephalitis Vaccination market size was valued at US$ 1263.1 million in 2023. With growing demand in downstream market, the Encephalitis Vaccination is forecast to a readjusted size of US$ 1875.5 million by 2030 with a CAGR of 5.8% during review period. The research report highlights the growth potential of the global Encephalitis Vaccination market. Encephalitis Vaccination are expected to show stable growth in the future m......
  • Global Avian Influenza Vaccines Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 123
    Market Overview of Global Avian Influenza Vaccines market: According to our latest research, the global Avian Influenza Vaccines market looks promising in the next 5 years. As of 2022, the global Avian Influenza Vaccines market was estimated at USD 933.69 million, and it's anticipated to reach USD 1586.45 million in 2028, with a CAGR of 9.24% during the forecast years. Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. ......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global 23-Valent Pneumococcal Polysaccharide Vaccine market size was valued at US$ 1114.7 million in 2023. With growing demand in downstream market, the 23-Valent Pneumococcal Polysaccharide Vaccine is forecast to a readjusted size of US$ 2265.8 million by 2030 with a CAGR of 10.7% during review period. The research report highlights the growth potential of the global 23-Valent Pneumococcal Polysaccharide Vaccine market. 23-Valent P......
  • Global Avian Influenza Vaccines Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Avian Influenza Vaccines market size was valued at US$ 928.4 million in 2023. With growing demand in downstream market, the Avian Influenza Vaccines is forecast to a readjusted size of US$ 1369 million by 2030 with a CAGR of 5.7% during review period. The research report highlights the growth potential of the global Avian Influenza Vaccines market. Avian Influenza Vaccines are expected to show stable growth in the future mark......
  • Global Encephalitis Vaccination Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Encephalitis Vaccination market: According to our latest research, the global Encephalitis Vaccination market looks promising in the next 5 years. As of 2022, the global Encephalitis Vaccination market was estimated at USD 52963.61 million, and it's anticipated to reach USD 65320.29 million in 2028, with a CAGR of 3.56% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis......
  • Global Influenza Vaccine Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 96
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Influenza Vaccine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Sanofi - CSL - GSK - Viatris - AstraZeneca - Hualan Bio - Changchun Institute of Biological - Sinovac - BCHT - Jiangsu G......
  • Global Japanese Encephalitis Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Japanese Encephalitis Vaccine market: According to our latest research, the global Japanese Encephalitis Vaccine market looks promising in the next 5 years. As of 2022, the global Japanese Encephalitis Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysi......
  • Global Influenza Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Influenza Vaccine market: According to our latest research, the global Influenza Vaccine market looks promising in the next 5 years. As of 2022, the global Influenza Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by influenza viruses... ......
  • 2023-2031 Report on Global Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel
    Published: 11-Dec-2023        Price: US 2500 Onwards        Pages: 107
    This report studies the Influenza Vaccine market, covering market size for segment by type (Inactivated Vaccine, Live Attenuated Vaccine, etc.), by application (Pediatric, Adults, etc.), by sales channel (Direct Channel, Distribution Channel), by player (CSL, GSK, Sanofi, Mylan, AstraZeneca, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Influenza Vaccine from......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs